Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ott, M. Allewelt, G. Korfmann, A. Kureishi, J. Lorenz, H. Lode (Berlin, Wuppertal, Luedenscheid, Germany). A novel approach in the treatment of aspiration pneumonia and primary lung abscess. Eur Respir J 2005; 26: Suppl. 49, 4219

Member's Comments

No comment yet.

Related content which might interest you: A patient with intractable pneumonia Source: Annual Congress 2006 - Interventional Pulmonology Grand Round: an interactive session Year: 2006 Empyema treatment: about drains, fibrinolytics and when to call the surgeon Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007 Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Source: Eur Respir J 2003; 22: 77S-83S Year: 2003 Non-antibiotic treatment for severe pneumonia? Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Are corticosteroids useful in community-acquired pneumonia? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Prophylactic antibiotics will affect the occurrence of post-bronchoscopic fever and pneumonia in patient with endobronchial obstructive lesions? Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Source: Eur Respir J 2006; 27: 158-164 Year: 2006 Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia Source: Eur Respir J 2002; 20: 1213-1219 Year: 2002 Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia Source: Eur Respir J 2002; 19: 944-951 Year: 2002 Pneumonia in children, pleural infection, necrotising pneumonia and lung abscess Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Necrotising pneumonia is an increasingly detected complication of pneumonia in children Source: Eur Respir J 2008; 31: 1285-1291 Year: 2008 A case of recurrent right lower lobe pneumonia Source: Annual Congress 2005 - Oncology Grand Round: an interactive session Year: 2005 Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Diagnostic importance of bronchial aspiration with protected catheter in COPD patients with unresolved community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 The approach to antibiotic treatment in community-acquired pneumonia Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia Year: 2008 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Pneumococcal pneumonia: an old disease with radically-new approaches for antibiotic therapy Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005